Emily Lewis, MS, CPDHTS, is an accomplished leader in digital health and AI. With nearly two decades of experience, she has made significant contributions to clinical decision support systems, using machine learning to accelerate patient treatment times. Emily has spearheaded the integration of large language models into electronic health records to reduce clinical workloads, and led the development of a software as a medical device (SaMD) tool now recognized by the FDA and EMA, with widespread implementation across multiple health systems.
A strong advocate for AI interpretability and transparency, Emily has developed frameworks and best practices that ensure compliance with international regulations. She has contributed to the advancement of post-market surveillance standards, laying out systems for continuous AI performance monitoring. Known for fostering cross-industry collaborations, Emily has driven partnerships between pharmaceutical companies, healthcare providers, and AI startups. She has also established educational programs to enhance healthcare AI literacy among clinicians and industry professionals. She has led multi-disciplinary teams and shaped corporate AI strategy and data governance. Through her thought leadership, speaking engagements, and publications, Emily remains at the forefront of healthcare innovation.
As clinicians begin to rely more on AI, they will also need to cultivate new skills, particularly around critical interpretation of AI-generated insights, to fully leverage its potential in patient care.